Saturday, October 31, 2026

Nikola Stock Went Down By Over 11% So Far Today

Nikola Stock Went Down By Over 11% So Far Today

Nikola Corporation's (NASDAQ:NKLA), a technology innovator and integrator based in Arizona, recently saw a dramatic drop in its shares by 11.06 per cent. This drop followed the overall trend of the stock market. This article sheds light on the corporation's stock market performance in the recent past and the factors affecting it.

Nikola's Stock Performance

The recent closing price of Nikola was 72.13% less than its 52-week high, indicating a bearish trend in its stock performance. This sharp downfall is a part of the global stock market volatility affecting many global markets. Over the last year, Nikola's return on equity has been a troubling negative 137.05%, escalating shareholder's disappointment over its inability to generate profits to compensate for their investments.

Growth Amid Decline

In contrast, a corporation that specializes in advanced energy and transportation solutions has managed to achieve an impressive year-on-year quarterly revenue growth of 489.1%. However, this substantial upswing had no positive effect on their stock price, showcasing the complex nature of stock markets.

Estimations and Reality

Despite the promising estimates for Nikola's future performance that suggest a growth of 37.9%, the corporation experienced a sales slump of 14.9% this quarter. Nikola's stock has displayed instability during its time on the market, with negative metrics dominating last week's trend. Nevertheless, an upward intraday variation average was observed for every month and quarter.

Nikola's Stock for Long-term Investors

For long-term investors, Nikola's stock has surpassed both its 50-day and 200-day moving averages. This suggests that those who maintained their investment for extended periods would have achieved significant returns, despite difficult market conditions. Therefore, when investing in Nikola or maintaining existing investments, it is essential that investors consider broader market trends along with individual company performance.

More news about Nikola (NKLA).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com